Bullfrog AI (BFRG) Competitors $2.29 +0.01 (+0.44%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends BFRG vs. CLRB, CUE, SPRO, SLS, SBFM, EPRX, GANX, ENTX, RAPT, and CTXRShould you be buying Bullfrog AI stock or one of its competitors? The main competitors of Bullfrog AI include Cellectar Biosciences (CLRB), Cue Biopharma (CUE), Spero Therapeutics (SPRO), SELLAS Life Sciences Group (SLS), Sunshine Biopharma (SBFM), Eupraxia Pharmaceuticals (EPRX), Gain Therapeutics (GANX), Entera Bio (ENTX), RAPT Therapeutics (RAPT), and Citius Pharmaceuticals (CTXR). These companies are all part of the "pharmaceutical products" industry. Bullfrog AI vs. Cellectar Biosciences Cue Biopharma Spero Therapeutics SELLAS Life Sciences Group Sunshine Biopharma Eupraxia Pharmaceuticals Gain Therapeutics Entera Bio RAPT Therapeutics Citius Pharmaceuticals Cellectar Biosciences (NASDAQ:CLRB) and Bullfrog AI (NASDAQ:BFRG) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, valuation, community ranking, media sentiment, earnings, dividends and risk. Which has more risk & volatility, CLRB or BFRG? Cellectar Biosciences has a beta of 1, meaning that its stock price has a similar volatility profile to the S&P 500.Comparatively, Bullfrog AI has a beta of -0.21, meaning that its stock price is 121% less volatile than the S&P 500. Do analysts recommend CLRB or BFRG? Cellectar Biosciences currently has a consensus price target of $21.00, suggesting a potential upside of 934.48%. Given Cellectar Biosciences' higher possible upside, equities research analysts clearly believe Cellectar Biosciences is more favorable than Bullfrog AI.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cellectar Biosciences 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Bullfrog AI 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A Which has higher valuation & earnings, CLRB or BFRG? Bullfrog AI has higher revenue and earnings than Cellectar Biosciences. Bullfrog AI is trading at a lower price-to-earnings ratio than Cellectar Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCellectar BiosciencesN/AN/A-$37.98M-$2.53-0.80Bullfrog AI$60K299.61-$5.36M-$0.84-2.73 Do insiders and institutionals have more ownership in CLRB or BFRG? 16.4% of Cellectar Biosciences shares are owned by institutional investors. Comparatively, 1.0% of Bullfrog AI shares are owned by institutional investors. 3.7% of Cellectar Biosciences shares are owned by company insiders. Comparatively, 33.9% of Bullfrog AI shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Does the MarketBeat Community prefer CLRB or BFRG? Cellectar Biosciences received 241 more outperform votes than Bullfrog AI when rated by MarketBeat users. CompanyUnderperformOutperformCellectar BiosciencesOutperform Votes24155.92% Underperform Votes19044.08% Bullfrog AIN/AN/A Is CLRB or BFRG more profitable? Cellectar Biosciences' return on equity of 0.00% beat Bullfrog AI's return on equity.Company Net Margins Return on Equity Return on Assets Cellectar BiosciencesN/A N/A -200.45% Bullfrog AI N/A -130.80%-117.12% Does the media prefer CLRB or BFRG? In the previous week, Cellectar Biosciences had 4 more articles in the media than Bullfrog AI. MarketBeat recorded 4 mentions for Cellectar Biosciences and 0 mentions for Bullfrog AI. Cellectar Biosciences' average media sentiment score of 1.00 beat Bullfrog AI's score of 0.00 indicating that Cellectar Biosciences is being referred to more favorably in the media. Company Overall Sentiment Cellectar Biosciences Positive Bullfrog AI Neutral SummaryCellectar Biosciences beats Bullfrog AI on 9 of the 14 factors compared between the two stocks. Ad Chaikin AnalyticsSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's what that means for your money. Billionaire Wall Street investors are quietly offloading millions of shares. What do they know that you don't? It's arguably the most popular stock in the world. Now, one 50-year Wall Street legend says its day in the sun could finally be coming to an end. Last year, he warned of two stocks that went on to crash 60%.Now he's just issued a warning for the most popular stock in the world: Nvidia (NVDA). Get Bullfrog AI News Delivered to You Automatically Sign up to receive the latest news and ratings for BFRG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BFRG vs. The Competition Export to ExcelMetricBullfrog AIPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$17.98M$7.02B$5.40B$8.53BDividend YieldN/A7.96%5.15%4.14%P/E Ratio-2.739.36112.5515.07Price / Sales299.61386.151,478.8293.55Price / CashN/A47.3339.8334.04Price / Book5.335.324.645.01Net Income-$5.36M$153.56M$119.13M$225.46M7 Day Performance-2.55%0.12%0.78%0.37%1 Month Performance-17.92%15.23%5.65%3.57%1 Year Performance-19.08%41.16%36.90%29.42% Bullfrog AI Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BFRGBullfrog AI1.19 of 5 stars$2.29+0.4%N/A-14.9%$17.98M$60,000.00-2.734Gap UpCLRBCellectar Biosciences2.583 of 5 stars$2.03-3.3%$21.00+934.5%-14.7%$72.78MN/A-0.6610Earnings ReportShort Interest ↓News CoverageCUECue Biopharma4.6538 of 5 stars$1.48-5.1%$5.00+237.8%-24.8%$71.99M$8.30M-1.5360Positive NewsGap UpHigh Trading VolumeSPROSpero Therapeutics4.5915 of 5 stars$1.33+5.6%$7.00+426.3%+3.5%$71.81M$103.78M4.0346News CoverageHigh Trading VolumeSLSSELLAS Life Sciences Group1.9406 of 5 stars$1.23+11.8%$3.00+143.9%+25.0%$71.04M$1M-1.3416SBFMSunshine Biopharma1.0754 of 5 stars$3.02+0.3%N/A-89.5%$70.70M$30.48M-0.013News CoveragePositive NewsEPRXEupraxia PharmaceuticalsN/A$2.58+3.6%N/AN/A$70.38MN/A-3.1929News CoverageGap UpGANXGain Therapeutics3.7516 of 5 stars$2.65-1.1%$7.33+176.7%-17.1%$67.65M$50,000.00-2.0420Short Interest ↓ENTXEntera Bio2.8872 of 5 stars$1.88+3.3%$10.00+431.9%+170.4%$67.27M$130,000.00-7.2320Short Interest ↓Gap UpRAPTRAPT Therapeutics3.6665 of 5 stars$1.89+6.8%$18.17+861.2%-84.3%$65.97M$1.53M-0.6180News CoveragePositive NewsCTXRCitius Pharmaceuticals2.301 of 5 stars$0.36+5.2%$4.00+998.9%-53.4%$65.77MN/A-1.5220Positive News Related Companies and Tools Related Companies Cellectar Biosciences Competitors Cue Biopharma Competitors Spero Therapeutics Competitors SELLAS Life Sciences Group Competitors Sunshine Biopharma Competitors Eupraxia Pharmaceuticals Competitors Gain Therapeutics Competitors Entera Bio Competitors RAPT Therapeutics Competitors Citius Pharmaceuticals Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:BFRG) was last updated on 11/2/2024 by MarketBeat.com Staff From Our PartnersEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bullfrog AI Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bullfrog AI With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BFRG Stock Alerts